Archit Organosys Board of Directors

Get the latest insights into the leadership at Archit Organosys. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Kandarp Amin Chairman & Wholetime Director
Mr. Archit Amin Whole Time Director
Mrs. Archana Amin Whole Time Director
Mr. Nikul Patel Independent Director
Mr. Shreeraj Desai Independent Director
Mr. Bhavin Shah Independent Director
Mr. Vatsal Vora Independent Director

Archit Organosys Share price

ARCHITORG

44.54

0.41 (-0.91%)
Last updated on 3 Sep, 2025 | 13:50 IST
BUYSELL
Today's High

45.85

Today's Low

43.51

52 Week Low

34.20

52 Week High

53.50

The current prices are delayed, login to your account for live prices

Archit Organosys FAQs

The board at Archit Organosys consists of experienced professionals, including Mr. Kandarp Amin , Mr. Archit Amin , and others, overseeing the company’s strategic and corporate governance.

Directors at Archit Organosys are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Kandarp Amin is the current chairman at Archit Organosys.

Executive directors at Archit Organosys are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Archit Organosys adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Archit Organosys, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.